Abstract
Study Objective
Lymphadenectomy is the most accurate method of assessment of lymph node involvement in carcinoma endometrium. The benefit of lymphadenectomy in endometrial cancer is still unproven. Sentinel lymph node (SLN) evaluation is of growing importance because of less morbidity and good diagnostic accuracy. Identification rates, sensitivity, specificity, negative predictive value and positive predictive value of SLNB in comparison with standard pelvic with/without para-aortic lymph node dissection were analyzed in present study.
Methodology
Intraoperatively Indocyanine Green (ICG) tracer is injected into the cervix at 3’o clock and 9’o clock position at a concentration of 0.5 mg/ml. Sentinel lymph nodes were traced with the help of near-infrared spectrum supported camera technology (SPIES Camera-Karl Storz/Stryker ICG 4 K camera) by laparoscopy. These SLNs were identified, dissected and evaluated separately for metastasis. Complete pelvic with/without para-aortic lymphadenectomy was done and compared with results of SLNB.
Main Results
Eighty-six patients of endometrioid endometrial carcinoma were analyzed from June 2017 to December 2020 at a single tertiary cancer center in India. 88.4% (76/86) had at least one sentinel lymph node traced. Nodal metastasis was found in 8.1% (7/86) patients. SLNB identified metastasis in 5/7 (71% sensitivity). The specificity and negative predictive value (NPV) of SLNB were 100% (97/97) and 98.9% (97/98), respectively. False negative rate was < 1% (1/101).
Conclusion
Laparoscopic sentinel lymph node biopsy (SLNB) with ICG is an acceptable method of staging of lymph nodes in endometrioid endometrial carcinoma with accuracy comparable to standard lymphadenectomy. It has a good specificity, NPV and acceptable false negative rate compared to standard lymphadenectomy.
Similar content being viewed by others
References
Ferlay J, Steliaova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.
https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
McPherson CP, Sellers TA, Potter JD, et al. Reproductive factors and risk of endometrial cancer. The Iowa Women’s Health Study. Am J Epidemiol. 1996;143:1195–202.
Hamilton CA, Cheung MK, Osann K, Chen L, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94:642–6.
Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003;91:463–9.
Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, et al. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multiinstitutional review. Gynecol Oncol. 2008;108:293–7.
Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125:531–5.
Burbos N, Musonda P, Duncan TJ, et al. Estimating the risk of endometrial cancer in symptomatic postmenopausal women: a novel clinical prediction model based on patients’ characteristics. Int J Gynecol Cancer. 2011;21:500–6.
Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. Can Med Assoc J. 2008;178(7):855–62.
Papadia A, Zapardiel I, Bussi B, Ghezzi F, Ceccaroni M, De Ponti E, et al. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc-99m with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol. 2017;143(3):475–80.
Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database of Systematic Reviews 2017, Issue 10. DOI: https://doi.org/10.1002/14651858.CD007585. pub4
Agar N, Philippe AC, Bourdel N, Rabischong B, Canis M, Le Bouedec G, et al. Morbidity of pelvic lymphadenectomy and para-aortic lymphadenectomy in endometrial cancer. Bull Cancer. 2015;102(5):428–35.
Biglia N, Librino A, Ottino MC, Panuccio E, Daniele A, Chahin A. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer. Int J Gynecol Cancer. 2015;25(3):521–5.
Zikan M, Fischerova D, Pinkavova I, Slama J, Weinberger V, Dusek L, et al. A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer. Gynecol Oncol. 2015;137(2):291–8.
van de Poll-Franse LV, Pijnenborg JM, Boll D, Vos MC, van den Berg H, Lybeert ML, et al. Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early stage endometrial carcinoma: a large population-based study. Gynecol Oncol. 2012;127(1):153–60.
S. Kang et al./Gynecologic Oncology 123 (2011) 522–527 (meta-analysis based on 26 eligible studies, which included 1101 SLN procedures).
Lawrie TA, Patel A, Martin-Hirsch PPL, Bryant A, Ratnavelu NDG, Naik R, et al. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. Cochrane Database of Systematic Reviews 2014, Issue 6. DOI: https://doi.org/10.1002/14651858.CD010409.pub2.
Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365–83.
Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.
Geppert, et al., Sentinel lymph node biopsy in endometrial cancer—Feasibility, safety and lymphatic complications, Gynecol Oncol (2017)
Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicenter, prospective, cohort study. Lancet Oncol. 2017; 18(3):384–92.https://doi.org/10.1016/S1470-2045 (17)30068–2.
Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicenter study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76 ([PubMed: 21489874]).
Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:459-76.e10.
Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicenter, non-inferiority trial. Lancet Oncol. 2018;19:1394–403.
Papadia A, Imboden S, Siegenthale F, Gasparri ML. Laparoscopic indocyanine green sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2016;23:2206–11. https://doi.org/10.1245/s10434-016-5090-x).
Rocha A, Dominguez AM, Lecuru F, Bourdel N. Indocyanine green and infrared fluorescence in detection of sentinel lymph nodes in endometrial and cervical cancer staging—a systematic review. Euro J Obstetrics Gynecol Reprod Biol. 2016;206:213–9. https://doi.org/10.1016/j.ejogrb.2016.09.027.
Eriksson AG, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, et al. Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery. Ann Surg Oncol. 2016;23(8):2522–8.
Somashekhar SP, Arvind R, Kumar CR, Ahuja V, Ashwin KR. Sentinel node mapping using indocyanine green and near-infrared fluorescence imaging technology for endometrial cancer: A prospective study using a surgical algorithm in Indian patients. J Min Access Surg 0; 0: 0. DOI: https://doi.org/10.4103/jmas.JMAS_154_20
Anupama Rajanbabu*, Reshu Agarwal. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes; Euro J Obstetrics Gynecol Reprod Biol. 224 (2018) 77–80; https://doi.org/10.1016/j.ejogrb.2018.03.017
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Madhunarayana, B., Rajagopalan Iyer, R., Patnaik, S.C. et al. ICG-Based Sentinel Lymph Node Biopsy in Endometrioid Endometrial Carcinoma—Results of a Prospective Study from a Single Tertiary Cancer Center of India. Indian J Gynecol Oncolog 19, 89 (2021). https://doi.org/10.1007/s40944-021-00586-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40944-021-00586-w